Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2024 Oct:92:102599.
doi: 10.1016/j.canep.2024.102599. Epub 2024 Jun 12.

Genetic variation near GRB10 associated with bone growth and osteosarcoma risk in canine and human populations

Affiliations
Multicenter Study

Genetic variation near GRB10 associated with bone growth and osteosarcoma risk in canine and human populations

Sydney E Lucas et al. Cancer Epidemiol. 2024 Oct.

Abstract

Background: Canine and human osteosarcoma are similar in clinical presentation and tumor genomics. Giant breed dogs experience elevated osteosarcoma incidence, and taller stature remains a consistent risk factor for human osteosarcoma. Whether evolutionarily conserved genes contribute to both human and canine osteosarcoma predisposition merits evaluation.

Methods: A multi-center sample of childhood osteosarcoma patients and controls underwent genome-wide genotyping and imputation. Ancestry-adjusted SNP associations were calculated within each dataset using logistic regression, then meta-analyzed across the three datasets, totaling 1091 patients and 3026 controls. Ten regions previously associated with canine osteosarcoma risk were mapped to the human genome, spanning ∼6 Mb. We prioritized association testing of 5985 human SNPs mapping to candidate osteosarcoma risk regions detected in Irish wolfhounds, the largest dog breed studied. Secondary analyses explored 6289 additional human SNPs mapping to candidate osteosarcoma risk regions identified in Rottweilers and greyhounds.

Results: Fourteen SNPs were associated with human osteosarcoma risk after adjustment for multiple comparisons, all within a 42 kb region of human Chromosome 7p12.1. The lead variant was rs17454681 (OR=1.25, 95 %CI: 1.12-1.39; P=4.1×10-5), and independent risk variants were not observed in conditional analyses. While the associated region spanned 2.1 Mb and contained eight genes in Irish wolfhounds, associations were localized to a 50-fold smaller region of the human genome and strongly implicate GRB10 (growth factor receptor-bound protein 10) in canine and human osteosarcoma predisposition. PheWAS analysis in UK Biobank data identified noteworthy associations of the rs17454681 risk allele with varied measures of height and pubertal timing.

Conclusions: Our comparative oncology analysis identified a novel human osteosarcoma risk allele near GRB10, a growth inhibitor that suppresses activated receptor tyrosine kinases including IGF1R, PDGFRB, and EGFR. Epidemiologists may benefit from leveraging cross-species comparisons to identify haplotypes in highly susceptible but genetically homogenous populations of domesticated animals, then fine-mapping these associations in diverse human populations.

Keywords: Comparative oncology; Genome-wide association study; Growth factor receptor bound protein 10; Insulin-like growth factor receptor; Osteosarcoma.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors have no relevant financial or personal interests to report or disclose.

Figures

FIGURE 1.
FIGURE 1.
Association of SNPs with childhood osteosarcoma risk in a region of chromosome 7p12.1 (1091 cases, 3026 controls), orthologous to a region previously associated with OS risk in Irish wolfhounds. The lead variant, rs17454681 (purple diamond), is ~63kb upstream of GRB10 (growth factor receptor-bound protein 10). Other SNPs are displayed by color, showing their extent of genetic linkage with rs17454681. Recombination rate, genetic position (37/hg19), and the locations of nearby genes are indicated.
FIGURE 2.
FIGURE 2.
Mixed-effects meta-analysis of the association between rs17454681 and osteosarcoma risk in three datasets, stratified by biological sex. The T allele is associated with OS risk among females (OR=1.33; 95%CI: 1.11–1.55) and among males (OR=1.18; 95%CI: 1.01–1.35), with differences in the magnitude of effect across strata of sex not reaching statistical significance (P=0.29).

References

    1. Savage SA, Mirabello L. Using epidemiology and genomics to understand osteosarcoma etiology. Sarcoma. 2011;2011:548151. Epub 2011/03/26. doi: 10.1155/2011/548151. - DOI - PMC - PubMed
    1. Mutsaers AJ, Walkley CR. Cells of origin in osteosarcoma: mesenchymal stem cells or osteoblast committed cells? Bone. 2014;62:56–63. Epub 2014/02/18. doi: 10.1016/j.bone.2014.02.003. - DOI - PubMed
    1. Mirabello L, Pfeiffer R, Murphy G, Daw NC, Patino-Garcia A, Troisi RJ, Hoover RN, Douglass C, Schuz J, Craft AW, Savage SA. Height at diagnosis and birth-weight as risk factors for osteosarcoma. Cancer Causes Control. 2011;22(6):899–908. Epub 2011/04/06. doi: 10.1007/s10552-011-9763-2. - DOI - PMC - PubMed
    1. Cotterill SJ, Wright CM, Pearce MS, Craft AW, Group UMBTW. Stature of young people with malignant bone tumors. Pediatr Blood Cancer. 2004;42(1):59–63. Epub 2004/01/31. doi: 10.1002/pbc.10437. - DOI - PubMed
    1. Mirabello L, Zhu B, Koster R, Karlins E, Dean M, Yeager M, Gianferante M, Spector LG, Morton LM, Karyadi D, Robison LL, Armstrong GT, Bhatia S, Song L, Pankratz N, Pinheiro M, Gastier-Foster JM, Gorlick R, de Toledo SRC, Petrilli AS, Patino-Garcia A, Lecanda F, Gutierrez-Jimeno M, Serra M, Hattinger C, Picci P, Scotlandi K, Flanagan AM, Tirabosco R, Amary MF, Kurucu N, Ilhan IE, Ballinger ML, Thomas DM, Barkauskas DA, Mejia-Baltodano G, Valverde P, Hicks BD, Zhu B, Wang M, Hutchinson AA, Tucker M, Sampson J, Landi MT, Freedman ND, Gapstur S, Carter B, Hoover RN, Chanock SJ, Savage SA. Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma. JAMA Oncol. 2020;6(5):724–34. Epub 2020/03/20. doi: 10.1001/jamaoncol.2020.0197. National Institutes of Health outside the submitted work. Dr Pankratz reported receiving grants from the National Institutes of Health outside the submitted work. No other disclosures were reported. - DOI - PMC - PubMed

Publication types

MeSH terms